High Efficacy of Sofosbuvir/Velpatasvir Plus GS-9857 for 12 Weeks in Treatment-Experienced Genotype 1-6 HCV-Infected Patients, Including Those Previously Treated with Direct-Acting Antivirals: 2016 ACG Presidential Poster Award
Year: 2016
Type: article
Authors: Erik Lawitz, Kris Kowdley, Michael Curry, Nancy Reau, Mindie Nguyen, Paul Kwo, Ira M. Jacobson, Tram Tran, Ronald Nahass, Frederico Hinestrosa, Robert Herring, Michael Bennett, Joseph Llewellyn, Jenny Yang, Luisa Stamm, Diana M. Brainard, John G. McHutchison, Eugene Schiff, Mitchell Davis, Kyle Etzkorn, Raymond Chung, David Pound, Maribel Rodriguez-Torres, Rajender K. Reddy, Edward Gane
Institutions: Texas Liver Institute, Swedish Medical Center, Beth Israel Deaconess Medical Center, Harvard University, Rush University Medical Center, Stanford Medicine, Mount Sinai Beth Israel, Cedars-Sinai Medical Center, Orlando Immunology Center, Gilead Sciences (United States), University of Miami Health System, Digestive CARE, Borland Groover Clinic, Massachusetts General Hospital, University of Pennsylvania Health System
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2978377119